Veterinary Medicines

Nobilis Gumboro 228E

Authorised
  • Infectious bursal disease virus, strain LZD 228E, Live
Download as PDF

Product identification

Medicine name:
Nobilis Gumboro 228E
Active substance:
  • Infectious bursal disease virus, strain LZD 228E, Live
Target species:
  • Chicken
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Infectious bursal disease virus, strain LZD 228E, Live
    3.00
    50% Embryo Infective Dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Powder for oral solution
Withdrawal period by route of administration:
  • Oral use
    • Chicken
      • Eggs
        0
        day
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD09
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Package description:
  • Sealed aluminium laminate cup with a polypropylene (cup) and polypropylene/polyethylene (lid) contact layer. Pack sizes presentation in cups: PET plastic box with 6 cups of 10000 doses
  • Sealed aluminium laminate cup with a polypropylene (cup) and polypropylene/polyethylene (lid) contact layer. Pack sizes presentation in cups: PET plastic box with 12 cups of 10000 doses
  • Sealed aluminium laminate cup with a polypropylene (cup) and polypropylene/polyethylene (lid) contact layer. Pack sizes presentation in cups: PET plastic box with 12 cups of 5000 doses
  • Sealed aluminium laminate cup with a polypropylene (cup) and polypropylene/polyethylene (lid) contact layer. Pack sizes presentation in cups: PET plastic box with 12 cups of 2500 doses
  • Sealed aluminium laminate cup with a polypropylene (cup) and polypropylene/polyethylene (lid) contact layer. Pack sizes presentation in cups: PET plastic box with 12 cups of 1,000 doses
  • Vial of hydrolytical type I glass (Ph. Eur.) containing the freeze-dried vaccine pellet. Contents and presentation: 10000 doses per vial in packs of 10 vials. The vials are closed with a halogenobutyl rubber stopper and sealed with a coded aluminium cap.
  • Vial of hydrolytical type I glass (Ph. Eur.) containing the freeze-dried vaccine pellet. Contents and presentation: 5000 doses per vial in packs of 10 vials. The vials are closed with a halogenobutyl rubber stopper and sealed with a coded aluminium cap.
  • Vial of hydrolytical type I glass (Ph. Eur.) containing the freeze-dried vaccine pellet. Contents and presentation: 2500 doses per vial in packs of 10 vials. The vials are closed with a halogenobutyl rubber stopper and sealed with a coded aluminium cap.
  • Vial of hydrolytical type I glass (Ph. Eur.) containing the freeze-dried vaccine pellet. Contents and presentation: 1000 doses per vial in packs of 10 vials. The vials are closed with a halogenobutyl rubber stopper and sealed with a coded aluminium cap.
  • Vial of hydrolytical type I glass (Ph. Eur.) containing the freeze-dried vaccine pellet. Contents and presentation: 500 doses per vial in packs of 10 vials. The vials are closed with a halogenobutyl rubber stopper and sealed with a coded aluminium cap.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet (Ireland) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • INTERVET INTERNATIONAL B.V.
Responsible authority:
  • HPRA
Authorisation number:
  • VPA10996/134/001
Date of authorisation status change:

Documents

Summary of Product Characteristics

English (PDF)
Published on: 8/04/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."